QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (54) Citing Articles via Google Scholar Google Scholar Articles by Jin, W. Articles by Mackie, K. Search for Related Content PubMed PubMed Citation Articles by Jin, W. Articles by Mackie, K.

 Previous Article  |  Next Article 

The Journal of Neuroscience, May 15, 1999, 19(10):3773-3780

Distinct Domains of the CB1 Cannabinoid Receptor Mediate Desensitization and Internalization

Wenzhen Jin¹, Sean Brown², John P. Roche^{2, 3}, Candace Hsieh², Jeremy P. Celver¹, Abraham Kovoor¹, Charles Chavkin¹, and Ken Mackie^{2, 3}

Departments of ¹ Pharmacology, ² Anesthesiology, and ³ Physiology and Biophysics, University of Washington, Seattle, Washington 98195-6540

Desensitization of cannabinoid receptor signaling by a G-protein coupled receptor kinase (GRK) was examined using the Xenopus oocyte expression system. Application of a CB1 agonist, WIN 55,212-2, evoked a concentration-dependent increase in K⁺ conductance (K_ir3) in oocytes coexpressing rat CB1 with the G-protein-gated, inwardly rectifying K⁺ channels K_ir3.1 and K_ir3.4. Desensitization was slight during continuous agonist application in the absence of GRK and arrestin. However, coexpression of GRK3 and -arrestin 2 (-arr2) caused profound homologous CB1 receptor desensitization, supporting the hypothesis that GRK3 and -arr2 effectively produce CB1 receptor desensitization. To identify the regions of the CB1 receptor responsible for GRK3- and -arr2-mediated desensitization, we constructed several CB1 receptor mutants. Truncation of the C-terminal tail of CB1 receptor at residue 418 (418) almost completely abolished desensitization but did not affect agonist activation of K_ir3. In contrast, truncation at residues 439 and 460 did not significantly affect GRK3- and -arr2-dependent desensitization. A deletion mutant (418-439) did not desensitize, indicating that residues within this region are important for GRK3- and -arr2-mediated desensitization. Phosphorylation in this region was likely involved in desensitization, because mutation of either of two putative phosphorylation sites (S426A or S430A) significantly attenuated desensitization. CB1 receptors rapidly internalize after activation by agonist. Phosphorylation of S426 or S430 was not necessary for internalization, because the S426A/S430A CB1 mutant internalized when stably expressed in AtT20 cells. These studies establish that CB1 desensitization can be regulated by a GRK and that different receptor domains are involved in GRK- and -arrestin-dependent desensitization and CB1 internalization.

Key words: cannabinoid; desensitization; inwardly rectifying potassium channel; G-protein-coupled receptor; -arrestin; G-protein coupled receptor kinase; phosphorylation

---

Copyright © 1999 Society for Neuroscience  0270-6474/99/19103773-08$05.00/0

This article has been cited by other articles:

				L. Mikasova, L. Groc, D. Choquet, and O. J. Manzoni Altered surface trafficking of presynaptic cannabinoid type 1 receptor in and out synaptic terminals parallels receptor desensitization PNAS, November 25, 2008; 105(47): 18596 - 18601. [Abstract] [Full Text] [PDF]

				B. W. Jones and P. M. Hinkle Arrestin Binds to Different Phosphorylated Regions of the Thyrotropin-Releasing Hormone Receptor with Distinct Functional Consequences Mol. Pharmacol., July 1, 2008; 74(1): 195 - 202. [Abstract] [Full Text] [PDF]

				D. L. McKinney, M. P. Cassidy, L. M. Collier, B. R. Martin, J. L. Wiley, D. E. Selley, and L. J. Sim-Selley Dose-Related Differences in the Regional Pattern of Cannabinoid Receptor Adaptation and in Vivo Tolerance Development to {Delta}9-Tetrahydrocannabinol J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 664 - 673. [Abstract] [Full Text] [PDF]

				J. L. Niehaus, Y. Liu, K. T. Wallis, M. Egertova, S. G. Bhartur, S. Mukhopadhyay, S. Shi, H. He, D. E. Selley, A. C. Howlett, et al. CB1 Cannabinoid Receptor Activity Is Modulated by the Cannabinoid Receptor Interacting Protein CRIP 1a Mol. Pharmacol., December 1, 2007; 72(6): 1557 - 1566. [Abstract] [Full Text] [PDF]

				S. Anavi-Goffer, D. Fleischer, D. P. Hurst, D. L. Lynch, J. Barnett-Norris, S. Shi, D. L. Lewis, S. Mukhopadhyay, A. C. Howlett, P. H. Reggio, et al. Helix 8 Leu in the CB1 Cannabinoid Receptor Contributes to Selective Signal Transduction Mechanisms J. Biol. Chem., August 24, 2007; 282(34): 25100 - 25113. [Abstract] [Full Text] [PDF]

				A. Tappe-Theodor, N. Agarwal, I. Katona, T. Rubino, L. Martini, J. Swiercz, K. Mackie, H. Monyer, D. Parolaro, J. Whistler, et al. A Molecular Basis of Analgesic Tolerance to Cannabinoids J. Neurosci., April 11, 2007; 27(15): 4165 - 4177. [Abstract] [Full Text] [PDF]

				P. Pacher, S. Batkai, and G. Kunos The Endocannabinoid System as an Emerging Target of Pharmacotherapy Pharmacol. Rev., September 1, 2006; 58(3): 389 - 462. [Abstract] [Full Text] [PDF]

				L. J. Sim-Selley, N. S. Schechter, W. K. Rorrer, G. D. Dalton, J. Hernandez, B. R. Martin, and D. E. Selley Prolonged Recovery Rate of CB1 Receptor Adaptation after Cessation of Long-Term Cannabinoid Administration Mol. Pharmacol., September 1, 2006; 70(3): 986 - 996. [Abstract] [Full Text] [PDF]

				N. Hejazi, C. Zhou, M. Oz, H. Sun, J. H. Ye, and L. Zhang {Delta}9-Tetrahydrocannabinol and Endogenous Cannabinoid Anandamide Directly Potentiate the Function of Glycine Receptors Mol. Pharmacol., March 1, 2006; 69(3): 991 - 997. [Abstract] [Full Text] [PDF]

				C. Leterrier, D. Bonnard, D. Carrel, J. Rossier, and Z. Lenkei Constitutive Endocytic Cycle of the CB1 Cannabinoid Receptor J. Biol. Chem., August 20, 2004; 279(34): 36013 - 36021. [Abstract] [Full Text] [PDF]

				J. Celver, M. Xu, W. Jin, J. Lowe, and C. Chavkin Distinct Domains of the {micro}-Opioid Receptor Control Uncoupling and Internalization Mol. Pharmacol., March 1, 2004; 65(3): 528 - 537. [Abstract] [Full Text] [PDF]

				H. Andersson, A. M. D'Antona, D. A. Kendall, G. Von Heijne, and C.-N. Chin Membrane Assembly of the Cannabinoid Receptor 1: Impact of a Long N-Terminal Tail Mol. Pharmacol., September 1, 2003; 64(3): 570 - 577. [Abstract] [Full Text] [PDF]

				G. Esposito, A. Ligresti, A. A. Izzo, T. Bisogno, M. Ruvo, M. Di Rosa, V. Di Marzo, and T. Iuvone The Endocannabinoid System Protects Rat Glioma Cells Against HIV-1 Tat Protein-induced Cytotoxicity. MECHANISM AND REGULATION J. Biol. Chem., December 20, 2002; 277(52): 50348 - 50354. [Abstract] [Full Text] [PDF]

				D. A. Eisinger, H. Ammer, and R. Schulz Chronic Morphine Treatment Inhibits Opioid Receptor Desensitization and Internalization J. Neurosci., December 1, 2002; 22(23): 10192 - 10200. [Abstract] [Full Text] [PDF]

				L. J. Sim-Selley and B. R. Martin Effect of Chronic Administration of R-(+)-[2,3-Dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone Mesylate (WIN55,212-2) or Delta 9-Tetrahydrocannabinol on Cannabinoid Receptor Adaptation in Mice J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 36 - 44. [Abstract] [Full Text] [PDF]

				M. Lamey, M. Thompson, G. Varghese, H. Chi, M. Sawzdargo, S. R. George, and B. F. O'Dowd Distinct Residues in the Carboxyl Tail Mediate Agonist-induced Desensitization and Internalization of the Human Dopamine D1 Receptor J. Biol. Chem., March 8, 2002; 277(11): 9415 - 9421. [Abstract] [Full Text] [PDF]

				M. Kouznetsova, B. Kelley, M. Shen, and S. A. Thayer Desensitization of Cannabinoid-Mediated Presynaptic Inhibition of Neurotransmission Between Rat Hippocampal Neurons in Culture Mol. Pharmacol., March 1, 2002; 61(3): 477 - 485. [Abstract] [Full Text] [PDF]

				J. Nie and D. L. Lewis Structural Domains of the CB1 Cannabinoid Receptor That Contribute to Constitutive Activity and G-Protein Sequestration J. Neurosci., November 15, 2001; 21(22): 8758 - 8764. [Abstract] [Full Text] [PDF]

				A. F. Hoffman and C. R. Lupica Mechanisms of Cannabinoid Inhibition of GABAA Synaptic Transmission in the Hippocampus J. Neurosci., April 1, 2000; 20(7): 2470 - 2479. [Abstract] [Full Text] [PDF]

				Y. Okamoto, H. Ninomiya, S. Miwa, and T. Masaki Cholesterol Oxidation Switches the Internalization Pathway of Endothelin Receptor Type A from Caveolae to Clathrin-coated Pits in Chinese Hamster Ovary Cells J. Biol. Chem., February 25, 2000; 275(9): 6439 - 6446. [Abstract] [Full Text] [PDF]

				J. P. Celver, J. Lowe, A. Kovoor, V. V. Gurevich, and C. Chavkin Threonine 180 Is Required for G-protein-coupled Receptor Kinase 3- and beta -Arrestin 2-mediated Desensitization of the {micro}-Opioid Receptor in Xenopus Oocytes J. Biol. Chem., February 9, 2001; 276(7): 4894 - 4900. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help